All abstracts
Home
Full programme
Live Sessions
Speakers
ePosters
All
Posters
Topics
Clear all filters
LB001
A REGRESSION-BASED APPROACH REVEALS SYMPTOMS AND CLINICAL FEATURES ASSOCIATED WITH IMPAIRED ENERGY INTAKE IN PATIENTS WITH HNC TREATED WITH RADICAL INTENT RADIOTHERAPY
LB002
INTERVENTION WITH PEA PROTEIN ORAL NUTRITION SUPPLEMENT REDUCES THERAPEUTIC GASTROSTOMY TUBE RATES IN PATIENTS WITH HEAD AND NECK CANCER UNDERGOING CHEMORADIATION THERAPY
LB003
PROTEIN INTAKE IN TODDLER FORMULA SHAPES URINARY METABOLOMIC PROFILES: RESULTS FROM THE TOMI TRIAL
LB004
A UK MULTICENTRE STUDY ASSESSING ACCEPTABILITY, GASTROINTESTINAL TOLERANCE AND COMPLIANCE OF A PAEDIATRIC BLENDED ENTERAL FORMULA ADMINISTERED VIA BOLUS GASTROSTOMY FEEDING
LB005
IMPACT OF TYPE 2 DIABETES MELLITUS, VITAMIN DEFICIENCIES, AND HYPOTHYROIDISM ON SHORT-TERM WEIGHT-LOSS OUTCOMES
LB007
12 WEEKS OF TIME-RESTRICTED EATING DID NOT CHANGE PHASE ANGLE IN ADULTS WITH OVERWEIGHT OR OBESITY: A SECONDARY ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL
LB008
DIGESTIVE KINETICS OF CARBOHYDRATE BLENDS SHAPE FERMENTATIVE METABOLISM AND MICROBIAL FUNCTION WITH RELEVANCE FOR METABOLIC NUTRITION
LB009
VARIATION IN DIETARY INTAKE ACROSS THE DAYS OF THE WEEK
LB010
NEXT-GENERATION AUTOMATED INTAKE MONITORING IN A HOSPITAL SETTING: FROM VOLUMETRY TO VISION-LANGUAGE MODELS
LB011
GASTRIC INHIBITORY POLYPEPTIDE (GIP) AS A POTENTIAL BIOMARKER OF NUTRITIONAL RESILIENCE IN ACUTE ILLNESS: A SECONDARY ANALYSIS OF THE RANDOMIZED CLINICAL TRIAL EFFORT
LB012
TUMBO SEED OIL ATTENUATES CARDIOMETABOLIC ALTERATIONS IN GUINEA PIGS WITH DIET-INDUCED HYPERLIPIDEMIA
LB013
PREDICTING GLYCEMIC IMPROVEMENT USING THE CLINICAL NUTRITION PROBLEM DIAGNOSTIC MATRIX FOR TYPE 2 DIABETES (CNP-DM)
LB014
SARCOPENIC OBESITY AT HOSPITAL DISCHARGE AND ITS THREE-MONTH EVOLUTION IN POST-CRITICAL COVID-19 PATIENTS: A NUTRIECOMUSCLE SUBSTUDY
LB015
FOOD TEXTURE-RELATED INTAKE AND WEIGHT STATUS IN ADOLESCENTS: SEX-SPECIFIC ASSOCIATIONS FROM A NATIONAL SURVEY
LB016
BEYOND CALORIES: AN AI-POWERED REAL-WORLD STUDY OF MACRO- AND MICRONUTRIENT INTAKE IN GLP-1 RECEPTOR AGONIST USERS COMPARED TO NON-USERS
LB017
NEUROMODULATION METHODOLOGIES TO TREAT OBESITY AND TYPE 2 DIABETES: NAIROBI STUDY
LB018
OSTEOPOROSIS IN TYPE 2 DIABETES.
LB019
PREVALENCE OF MALNUTRITION RISK FACTORS AND REFERRAL TO DIETETIC COUNSELING IN EUROPEAN AND LATIN AMERICAN PRIMARY CARE PATIENTS: A NUTRITIONDAY 2023–2024 STUDY
LB020
PHENOTYPIC DISCORDANCE IN TYPE 1 DIABETES: SERGI EQUATION PREDICTS CELLULAR RISK BETTER THAN TRADITIONAL SARCOPENIA INDICES
LB021
THE TRIGLYCERIDE–GLUCOSE INDEX AND HYPERTENSION IN KOREAN ADULTS: GENETIC INSIGHTS INTO METABOLIC HETEROGENEITY
1282
abstracts
1
2
...
65